Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 199

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 199
---
 |     |              | — |     |       |       — |

| (1) | Messrs. Khan and Nimocks are employees of our Sponsor and did not receive any compensation, equity or non-equity awards or other payments in their capacities as non-employee members of the Board of Managers of Legence Parent. |

| (2) | In December 2020, Mr. Keenen was granted 354.99 Series A Profits Interests. The Series A Profits Interests                                                                                                                                              
 represent membership interests in Legence Parent that are intended to constitute profits interests for U.S. federal income tax purposes. Despite the fact that the Series A Profits Interests do not require the payment of an exercise price, they are 
 most similar economically to stock options. Accordingly, they are classified as “options” under the definition provided in Item 402(a)(6)(i) of Regulation S-K as an instrument with an                                                                 
 “option-like feature.” For more information about the Series A Profits Interests, including their vesting and forfeiture terms, see the section entitled “—Elements of Compensation—Long-Term Equity Based                                              
 Compensation—Series A Plan.”                                                                                                                                                                                                                            |

Company 2025 Omnibus Incentive Plan In order to incentivize our employees and other service providers following the completion of this offering, we anticipate that our board will adopt the 2025 Plan for eligible employees, consultants, and directors prior to the completion of this offering. Our named executive officers will be eligible to participate in the 2025 Plan, which we expect will become effective upon the consummation of this offering. We anticipate that the 2025 Plan will provide for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, stock awards, dividend equivalents, other stock-based awards, cash awards, and substitute awards intended to align the interests of service providers, including our named executive officers, with those of our stockholders. 132

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 PRINCIPAL AND SELLING STOCKHOLDERS The following table sets forth certain information regarding the beneficial ownership of our Class A Common Stock and Class B Common Stock as of the date of effectiveness of this registration statement, after giving effect to the Corporate Reorganization described under “Corporate Reorganization” with respect to:

| • |     | each person known to us to beneficially own more than 5% of any class of our outstanding